SpravatoSPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat:

  • Adults with treatment-resistant depression (TRD)
  • Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions 

What is the SPRAVATO® treatment process?

SPRAVATO® can only be administered by a certified SPRAVATO® treatment center. You will administer the nasal spray yourself under the supervision of a healthcare provider.

There will be an observation period of at least two hours during which you will be allowed to rest comfortably while a healthcare provider monitors you for possible side effects. Your blood pressure will be assessed both prior to administration as well as at periodic intervals after you administer the nasal spray.

Because of the possible side effects affecting mental alertness and motor coordination, you won’t be able to drive, operate machinery, or do anything where where you need to be completely alert until the next day, following a restful sleep. You will need to coordinate transportation on your treatment days.

You should plan to attend treatment sessions two times per week in weeks 1-4, followed by once per week in weeks 5-8, followed by periodic sessions based on your response and your physician’s recommendation.

Kansas City Psychiatric Group, PA
8300 College Blvd., Suite 320  •  Overland Park, Kansas 66210  •  913-338-0400